• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Stability and immunogenicity of empty particles of foot-and-mouth disease virus.

作者信息

Rweyemamu M M, Terry G, Pay T W

出版信息

Arch Virol. 1979;59(1-2):69-79. doi: 10.1007/BF01317896.

DOI:10.1007/BF01317896
PMID:218538
Abstract

Three strains of foot-and-mouth disease virus were shown to contain significant amounts of naturally occurring 75S, empty particles as well as the infectious, 140S full particles. One of these strains--A Pando (1970)--was studied in detail. The empty particles from this virus strain were shown to have an observed sedimentation coefficient of 67S in 0.04 M phosphate buffer; they were labile in SDS, non-infectious and probably RNA-free and, on heating, they broke down to 12S subunits as did the 140S particles. The empty particles differed from the full particles in their polypeptide composition since they contained VP0, but there was no evidence for a diminished content of VP4. The 75S particles were shown to be present in significant amounts and to be stable to AEI inactivation. At 4 degrees C they were stable for at least two years. In guinea pigs they were as immunogenic as the 140S particles. The antisera raised against the 75S particles had the same serological specificity in neutralization tests as sera prepared against the 140S particle. It was concluded that the 75S particles from the A Pando (1970) strain of FMD virus may provide as important a contribution as 140S particles to the immunogenicity of inactivated vaccines prepared from this virus strain.

摘要

相似文献

1
Stability and immunogenicity of empty particles of foot-and-mouth disease virus.
Arch Virol. 1979;59(1-2):69-79. doi: 10.1007/BF01317896.
2
A comparative chemical and serological study of the full and empty particles of foot-and mouth disease virus.口蹄疫病毒完整颗粒与空壳颗粒的化学及血清学比较研究
J Gen Virol. 1975 Mar;26(3):227-38. doi: 10.1099/0022-1317-26-3-227.
3
Structure and immunogenicity of experimental foot-and-mouth disease and poliomyelitis vaccines.实验性口蹄疫疫苗和脊髓灰质炎疫苗的结构与免疫原性
Vaccine. 1995 Nov;13(16):1603-10. doi: 10.1016/0264-410x(95)00079-g.
4
Analysis of foot-and-mouth disease virus type O1 Brugge neutralization epitopes using monoclonal antibodies.利用单克隆抗体分析O1布吕赫口蹄疫病毒中和表位
J Gen Virol. 1986 Oct;67 ( Pt 10):2083-92. doi: 10.1099/0022-1317-67-10-2083.
5
Characterization of the minor polypeptides in the foot-and-mouth disease particle.口蹄疫病毒颗粒中次要多肽的特性分析
J Gen Virol. 1976 Apr;31(1):35-46. doi: 10.1099/0022-1317-31-1-35.
6
The specific detection of foot-and-mouth disease virus whole particle antigen (140S) by enzyme labelled immunosorbent assay.酶联免疫吸附测定法对口蹄疫病毒全病毒粒子抗原(140S)的特异性检测
J Hyg (Lond). 1979 Aug;83(1):127-34. doi: 10.1017/s0022172400025894.
7
Thermal stability of foot-and-mouth disease virus.口蹄疫病毒的热稳定性
Arch Virol. 1981;70(1):21-32. doi: 10.1007/BF01320790.
8
Comparative immunogenicity of 146S, 75S and 12S particles of foot-and-mouth disease virus.
Arch Virol. 1982;73(2):185-91. doi: 10.1007/BF01314726.
9
Serological and immunological relations between the 146S and 12S particles of foot-and-mouth disease virus.口蹄疫病毒146S和12S颗粒之间的血清学和免疫学关系。
J Gen Virol. 1980 Oct;50(2):369-75. doi: 10.1099/0022-1317-50-2-369.
10
Estimation of 140S particles in foot-and-mouth disease virus (FMDV) vaccine by using the computer analyzing system.利用计算机分析系统对口蹄疫病毒(FMDV)疫苗中140S颗粒进行评估。
Nihon Juigaku Zasshi. 1990 Jun;52(3):621-30. doi: 10.1292/jvms1939.52.621.

引用本文的文献

1
Effects of binary ethyleneimine and formaldehyde inactivation methods on foot-and-mouth disease virus vaccine immune responses and kinetics.双乙烯亚胺和甲醛灭活方法对口蹄疫病毒疫苗免疫反应及动力学的影响
Sci Rep. 2025 Sep 30;15(1):33788. doi: 10.1038/s41598-025-01292-9.
2
Self-Assembling E2-Based Nanoparticles Improve Vaccine Thermostability and Protective Immunity against CSFV.基于自我组装 E2 的纳米颗粒可提高疫苗热稳定性和对 CSFV 的保护免疫。
Int J Mol Sci. 2024 Jan 2;25(1):596. doi: 10.3390/ijms25010596.
3
Development of Foot-and-Mouth Disease Vaccines in Recent Years.

本文引用的文献

1
Polyoma transformation of hamster cell clones--an investigation of genetic factors affecting cell competence.仓鼠细胞克隆的多瘤病毒转化——对影响细胞感受态的遗传因素的研究
Virology. 1962 Feb;16:147-51. doi: 10.1016/0042-6822(62)90290-8.
2
A 65 S PARTICLE CONTAINING VIRAL PROTEIN IN CELLS INFECTED WITH FOOT-AND-MOUTH DISEASE VIRUS.
Virology. 1965 Jun;26:372-4. doi: 10.1016/0042-6822(65)90286-2.
3
PURIFICATION OF RADIOACTIVE FOOT-AND-MOUTH DISEASE VIRUS.放射性口蹄疫病毒的纯化
近年来口蹄疫疫苗的发展
Vaccines (Basel). 2022 Oct 28;10(11):1817. doi: 10.3390/vaccines10111817.
4
An Engineered Maturation Cleavage Provides a Recombinant Mimic of Foot-and-Mouth Disease Virus Capsid Assembly-Disassembly.一种工程化成熟切割提供了口蹄疫病毒衣壳组装-拆卸的重组模拟物。
Life (Basel). 2021 May 29;11(6):500. doi: 10.3390/life11060500.
5
A Heat-Induced Mutation on VP1 of Foot-and-Mouth Disease Virus Serotype O Enhanced Capsid Stability and Immunogenicity.口蹄疫病毒 O 型 VP1 热诱导突变增强了衣壳稳定性和免疫原性。
J Virol. 2021 Jul 26;95(16):e0017721. doi: 10.1128/JVI.00177-21.
6
Optimized Adenoviral Vector That Enhances the Assembly of FMDV O1 Virus-Like Particles Increases Its Potential as Vaccine for Serotype O Viruses.优化的腺病毒载体可增强口蹄疫病毒O1型病毒样颗粒的组装,提高其作为O型病毒疫苗的潜力。
Front Microbiol. 2020 Nov 4;11:591019. doi: 10.3389/fmicb.2020.591019. eCollection 2020.
7
Towards improvements in foot-and-mouth disease vaccine performance.致力于提高口蹄疫疫苗的性能。
Acta Vet Scand. 2020 May 20;62(1):20. doi: 10.1186/s13028-020-00519-1.
8
Immune response in cattle inoculated with the recombinant complete polyprotein of foot-and-mouth disease virus from larvae.用来自幼虫的口蹄疫病毒重组完整多聚蛋白接种牛后的免疫反应。
Chin Sci Bull. 2007;52(20):2805-2810. doi: 10.1007/s11434-007-0436-1.
9
A Prime-Boost Vaccination Strategy in Cattle to Prevent Foot-and-Mouth Disease Using a "Single-Cycle" Alphavirus Vector and Empty Capsid Particles.一种使用“单周期”甲病毒载体和空衣壳颗粒的牛用初免-加强免疫接种策略来预防口蹄疫。
PLoS One. 2016 Jun 13;11(6):e0157435. doi: 10.1371/journal.pone.0157435. eCollection 2016.
10
Construction and characterization of recombinant human adenovirus type 5 expressing foot-and-mouth disease virus capsid proteins of Indian vaccine strain, O/IND/R2/75.表达印度疫苗株O/IND/R2/75口蹄疫病毒衣壳蛋白的重组人5型腺病毒的构建与鉴定
Vet World. 2015 Feb;8(2):147-55. doi: 10.14202/vetworld.2015.147-155. Epub 2015 Feb 10.
Nature. 1963 Sep 21;199:1168-70. doi: 10.1038/1991168a0.
4
IN VITRO MEASUREMENT OF THE POTENCY OF INACTIVATED FOOT-AND-MOUTH DISEASE VIRUS VACCINES.灭活口蹄疫病毒疫苗效力的体外测定
J Hyg (Lond). 1963 Sep;61(3):345-51. doi: 10.1017/s0022172400039632.
5
THE USE OF ACETYLETHYLENEIMINE IN THE PRODUCTION OF INACTIVATED FOOT-AND-MOUTH DISEASE VACCINES.乙酰亚乙基胺在口蹄疫灭活疫苗生产中的应用。
J Hyg (Lond). 1963 Sep;61(3):337-44. doi: 10.1017/s0022172400039620.
6
Some functional and morphological alterations occurring during and after the adaptation of BHK 21 clone 13 cells to suspension culture.BHK 21克隆13细胞适应悬浮培养期间及之后发生的一些功能和形态学改变。
Exp Cell Res. 1966 Oct;44(1):119-28. doi: 10.1016/0014-4827(66)90418-6.
7
Antibody response to viral antigens.对病毒抗原的抗体反应。
Adv Immunol. 1973;17:195-253. doi: 10.1016/s0065-2776(08)60733-6.
8
A simple method for the quantification of 140S particles of foot-and-mouth disease virus (FMDV).一种用于定量口蹄疫病毒(FMDV)140S颗粒的简单方法。
Arch Gesamte Virusforsch. 1974;45(4):362-4. doi: 10.1007/BF01242879.
9
In vitro method for safety testing of foot-and-mouth disease vaccines.口蹄疫疫苗安全性检测的体外方法
J Hyg (Lond). 1970 Jun;68(2):159-72. doi: 10.1017/s0022172400028643.
10
Evidence for an internal antigen in foot-and-mouth disease virus.口蹄疫病毒内部抗原的证据。
J Gen Virol. 1969 Jun;4(4):479-87. doi: 10.1099/0022-1317-4-4-479.